MedPageToday.com

(MedPage Today) -- Many new cancer drugs did not extend overall survival on follow-up, researchers found

(MedPage Today) -- Early randomized trial of capivasertib shows promise in ER-positive disease

(MedPage Today) -- Older, unmarried, African-American patients more likely to say 'no'

(MedPage Today) -- Lower 2-year recurrence rate versus adjuvant therapy but not significantly

(MedPage Today) -- Population-based study sparks ideas on tackling the elevated risk

(MedPage Today) -- Simple procedures cut odds of post-op infection, study finds

(MedPage Today) -- ACE inhibitor or beta-blocker cuts cardiotoxicity in patients treated with trastuzumab and anthracyclines

(MedPage Today) -- ACLU, medical societies, even some biotech companies argue patients would be harmed

(MedPage Today) -- Medical fitness and anatomy remain important factors in selecting procedures for appropriate patients, new study shows

(MedPage Today) -- Diagnosis made nearly 7 months later than for women in low-deductible plans

(MedPage Today) -- Prospective diary-based study suggests a strategy for controlling the risk

(MedPage Today) -- Charles Adler is working on a potential diagnostic test

(MedPage Today) -- Benefit seen across all subgroups for patients with platinum-sensitive disease

(MedPage Today) -- Diagnostic criteria for disease types need updating for better patient stratification

(MedPage Today) -- Kevin Campbell dissects a new study on the cost of care cascades after testing

(MedPage Today) -- And how you can fix it

(MedPage Today) -- Survey finds half of men and nearly three-quarters of women in field have experienced sexual harassment

(MedPage Today) -- A 35-year-old HIV-infected patient who had recently started HAART therapy went to urgent care very concerned about a large group of vesicles that had appeared on her leg. For several days before the lesions appeared, she had experienced a burning skin sensation. Other symptoms included headache, neck pain, and fatigue. Can you diagnose the patient?

(MedPage Today) -- Particular risks linked with use of corticosteroids

(MedPage Today) -- Hiding incidents perpetuates the problem; openness, metrics, and hard goals needed